Transporin Inc. is an R & D company with full ownership of IP rights to a broad array of life science and software technologies. Expert Journal(TM) is Transporin's flagship product in expert clinical knowledge management. The unit of knowledge is the retrospective ("Retro") which provides, for the first time, specific visual and compact data comparisons of key clinical data from paired studies. The images are rendered on-the-go, on mobile devices fully integrated with Twitter(TM) and FaceBook(TM), Transporin's MBD transporter platform supports a range of extraordinary products facilitating the targeted delivery of interventions inside the human body. Its Transfexa(TM) line of generic reagents enables researchers to deliver nucleic acids intracellularly both in vitro and in vivo with a precision and effectiveness not hitherto possible (and without requiring lipid-based carriers).
